Vertex Pharmaceuticals Inc. (VRTX)

Index: Nasdaq 100
2.52%
$1.90
$77.22
02:16 09/12/16
Apply Now
Your capital is at risk
$77.22
02:16 09/12/16
DAILY VARIATION
2.52%
$1.90
VOLUME
1,773,434
DATA
52 Week High
$127.87
52 Week Low
$75.32
Shares Issued
247.78m
Market Cap
$19,133.47m
RiskGrade
224
Beta
1.85
MENU

Vertex Pharmaceuticals Inc. Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -45.2% -5.9%
ROCE 0.0%
Latest F'cast
P/E 33.4 11,398.7
PEG -1.3 -1.5
Pr/Revenue 18.5 11.3
Pr/Book 17.5
Latest F'cast
Revenue 77.9% -29.8%
PBT 0.0% n/a
EPS -26.4% -72.6%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2011-12-31 1,410.63 60.44 14.00¢ 237.2 0.0 n/a n/a 0.0%
2012-12-31 1,527.04 -12.38 -50.00¢ -83.8 0.0 n/a n/a 0.0%
2013-12-31 1,211.97 -626.04 -198.00¢ -37.5 0.0 n/a n/a 0.0%
2014-12-31 580.41 -734.88 314.00¢ 37.8 0.0 n/a n/a 0.0%
2015-12-31 1,032.34 -557.80 231.00¢ 54.5 -2.1 -26% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2016-12-31 1,693.33 -99.92 77.81c 11,398.7 -171.9 -66% 0.00c 0.0%
2017-12-31 2,242.47 337.01 236.50c 3,918.3 19.2 204% 0.00c 0.0%

Regulatory News

No results found

Newspaper Links

No results found